Clinical trials
Completed Hodgkin Disease trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Akeso | 1 |
| CStone Pharmaceuticals | 1 |
| Innovent Biologics (Suzhou) Co. Ltd. | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Cancer Institute (NCI) | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 7 |
| Leukemia | 1 |
| Lymphoma | 1 |
| Lymphoma, Follicular | 1 |
| Lymphoma, Large-Cell, Anaplastic | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.